SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 194.30 |
| Enterprise Value ($M) | 146.69 |
| Book Value ($M) | 25.05 |
| Book Value / Share | 0.31 |
| Price / Book | 7.76 |
| NCAV ($M) | 13.18 |
| NCAV / Share | 0.16 |
| Price / NCAV | 14.74 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 1.25 |
| Return on Assets (ROA) | 0.23 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.73 |
| Current Ratio | 1.73 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 86.63 |
| Assets | 98.50 |
| Liabilities | 73.45 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 138.10 |
| Operating Income | 25.00 |
| Net Income | 31.87 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -86.23 |
| Cash from Investing | 99.70 |
| Cash from Financing | 7.52 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Seven Fleet Partners LP | 0.20 | ||
| 13G | Longitude Capital Partners V, LLC | 7.30 | ||
| 13G | Venrock Healthcare Capital Partners III, L.P. | 8.20 | ||
| 13G/A | Tang Capital Management Llc | 8.40 | -14.00 | |
| 13G | Point72 Asset Management, L.P. | 8.30 | ||
| 13G/A | Janus Henderson Group Plc | 0.00 | -100.00 | |
| 13G/A | Cormorant Asset Management, LP | 0.00 | -100.00 | |
| 13G/A | Biotechnology Value Fund L P | 9.99 | 20.69 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 512,559 | 2,127,687 | 24.09 | |
| 864,183 | 2,028,906 | 42.59 | |
| 346,273 | 1,465,367 | 23.63 | |
| 545,967 | 2,763,025 | 19.76 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRBU – Caribou Biosciences, Inc. | CRGX – CARGO Therapeutics, Inc. |
| CRNX – Crinetics Pharmaceuticals, Inc. | CYTK – Cytokinetics, Incorporated |
| DAWN – Day One Biopharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io